Incyte Corp
Change company Symbol lookup
Select an option...
INCY Incyte Corp
RHCGF Ryman Healthcare Ltd
CSCO Cisco Systems Inc
UTZ UTZ Brands Inc
BSQR Bsquare Corp
APYX Apyx Medical Corp
XPEV Xpeng Inc
STX Seagate Technology Holdings PLC
EL Estee Lauder Companies Inc
CHND China Media Inc
Go

Health Care : Biotechnology | Mid Cap Growth
Company profile

Incyte Corporation is a biopharmaceutical company, which is focused on the discovery, development, and commercialization of therapeutics. The Company also conducts commercial and clinical development operations from its European headquarters in Morges, Switzerland, and Japanese office in Tokyo and Canadian headquarters in Montreal. It operates in two therapeutic areas, One therapeutic area is Hematology/Oncology, which is comprised of Myeloproliferative Neoplasms and Graft-Versus-Host Disease, as well as solid tumors and hematologic malignancies. The other therapeutic area is Inflammation and Autoimmunity, which includes its Dermatology commercial franchise. Its hematology and oncology franchise is comprised of four products, which are JAKAFI (ruxolitinib), MONJUVI (tafasitamab-cxix)/MINJUVI (tafasitamab), PEMAZYRE (pemigatinib) and ICLUSIG (ponatinib), as well as other clinical development programs. Its Dermatology commercial franchise is comprised of OPZELURA (ruxolitinib) cream.

Premarket

Last Trade
Delayed
$80.69
0.9703 (1.22%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$79.72
Day's Change
0.00 (0.00%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
1,201

10-day average volume:
1,364,999
1,201

Upcoming Events

INCY's fiscal year ends in December
There are no upcoming events for INCY

Past Earnings

This page reports .
DateEvent descriptionEarnings per
share actual
Earnings
estimate range
Previous year's
actual
May 3, 2022Q1 2022 Earnings Release$0.55$0.39 to $0.95$0.67
February 8, 2022Q4 2021 Earnings Release$0.10$0.67 to $1.09$0.93
November 2, 2021Q3 2021 Earnings Release$1.18$0.49 to $0.874$0.23
August 3, 2021Q2 2021 Earnings Release$0.80$0.61 to $0.88$1.24

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

, , , Copyright © 2022. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.